Update : January 27, 2012

ACC 2010
ESC 2010
TCT 2010
ACC 2009
AHA 2009
ESC 2009
TCT 2009
Meeting Briefs > AHA 2009

 
Summarized by Jong-Young Lee, MD (Asan Medical Center)
1. ARBITER 6-HALTS HDL And LDL Treatment Strategies
Source: Presented by Allen J. Taylor at: AHA 2009
2. The Impact of Different Treatment Strategies on Cardiac Death and MI Rates in Patients with Type 2 Diabetes and Stable Coronary Disease: A Report from BARI 2D
Source: Presented by Bernard R. Chaitman at: AHA 2009
3. Clopidogrel And Aspirin Versus Aspirin Alone After Coronary Bypass Surgery
The Clopidogrel After Surgery For Coronary Artery Disease (CASCADE) Randomized Controlled Trial
Source: Presented by Alexander Kulik at: AHA 2009
4. CHAMPION PCI
Source: Presented by Robert A. Harrington at: AHA 2009
5. CHAMPION PLATFORM
Source: Presented by Deepak L. Bhatt at: AHA 2009
6. Impact of Thrombectomy with EXPort catheter in Infarct Related Artery during Primary PCI on Procedural Outcome in patients with AMI (EXPIRA Trial). 24 Months Clinical Outcome
Source: Presented by Gennaro Sardella at: AHA 2009
7. FRANCE Registry: FRench Aortic National Corevalve and Edwards Registry
Source: Presented by Helene Eltchaninoff at: AHA 2009
8. Comparison of Low-Dose Versus High-Dose Losartan Treatment on Morbidity and Mortality in Angiotensin-Converting-Enzyme-Inhibitor-Intolerant Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction: Results of the HEAAL* Study
Source: Presented by Marvin A. Konstam at: AHA 2009
9. Randomized Trial to Optimize the Dose and Efficacy of Beta-Blocker in Systolic Heart Failure: Japanese Chronic Heart Failure (J-CHF) Study
Source: Presented by Masatsugu Hori at: AHA 2009
10. Long-term Cardiac and NeurocognitiveOutcome After Off- pump Coronary Artery Bypass Grafting (OPCAB) Versus PercutaneousCoronary Intervention (PCI)
Source: Presented by Jakub J Regieli at: AHA 2009
11. Paclitaxel-Eluting PTCA-Balloon in Combination with the Coroflex Blue Stent vs
the Sirolimus Coated Cypher Stent in the Treatment of Advanced Coronary Artery Disease
Source: Presented by C. W. Hamm at: AHA 2009
12. Outcomes in patients with STEMI and planned PCI
Source: Presented by Ph.Gabriel Steg at: AHA 2009
13. Non-Steroidal Anti-Inflammatory (NSAIDs) Treatment for Post-Operative Pericardial Effusion: The POPE Study : A Multicenter, Double-Blind, Randomized Trial
Source: Presented by Ph Meurin at: AHA 2009
14. Do Platelet Function Assays Predict Clinical Outcomes in clopidogrel pretreated patients undergoing elective PCI
Source: Presented by Nicoline J Breet at: AHA 2009
15. Radial Access Versus Conventional Femoral Puncture: Outcome and Resource Effectiveness in a Daily Routine. The RAPTOR-Trial
Source: Presented by Tim G. Schaufele at: AHA 2009
16. Differences in Clinical Outcomes with Rhythm and Rate Control Therapies for Atrial Fibrillation in the RecordAF Registry
Source: Presented by A. John Camm at: AHA 2009
17. Randomised Dabigatran Etexilate Dose Finding Study In Patients With Acute Coronary Syndromes Post Index Event With Additional Risk Factors For Cardiovascular Complications Also Receiving Aspirin and Clopidogrel
Source: Presented by J Oldgren at: AHA 2009
18. Efficacy and Safety of Dabigatran Compared to Warfarin at Different Levels of INR Control for Stroke Prevention in 18,113 patients with Atrial Fibrillation in the RE-LY Trial
Source: Presented by Lars Wallentin at: AHA 2009